Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2015-03-05

Clinical Trial Update: Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia [Phase 1, Phase 2]

View source ↗

Summary

Status update for a Phase 1/2 safety study of MultiGeneAngio in Chronic Critical Limb Ischemia, currently listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MultiGeneAngio

Snippet

Sponsor: MultiGene Vascular Systems Ltd. | Conditions: Peripheral Arterial Disease, Peripheral Vascular Disease | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING